Get in touch

Tiefenbacher Pharmaceuticals First to Market Launch: Varenicline in Europe

Tiefenbacher Group - A young woman stands outdoors with her eyes closed and hands on her chest, appearing calm and content. Text reads: "Launch of Varenicline across European Union." Tiefenbacher Pharmaceuticals, a family-owned pharmaceutical company, logo is at the top.

Tiefenbacher Pharmaceuticals successfully prepares the launch of Varenicline in the European Union We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be available and affordable for patients all around the world. That´s why we are thrilled to share that we have successfully prepared the launch of the only available Varenicline containing product in Europe. WHO has […]

Tiefenbacher Laboratories Blood Donation Camp

Tiefenbacher Group - Two men in formal attire cut a red ribbon at an event in front of a banner reading "Blood Donation Campaign" at Tiefenbacher Laboratories, a leader in generic medicines manufacturing. A blue label highlights the blood donation campaign.

Tiefenbacher Laboratories celebrates “International Humanitarian Day” with a blood donation campToday we are celebrating “International Humanitarian Day” with a blood donation camp on our Tiefenbacher Laboratories premises in Hyderabad (India), where our employees are donating blood to Indian Red Cross Society (NGO). The donated blood is mainly used for children with hemoglobinopathies such as thalassemia […]

Pioneering Healthcare at Tiefenbacher Group

Tiefenbacher Group - A man in a blue shirt stands by a window, softly smiling. A quote about pioneering pharmaceutical healthcare solutions is displayed beside him, along with the Tiefenbacher Group logo and the caption "Pioneering Healthcare at Tiefenbacher Group.

Curiosity Driven, Excellence Focused, Patient CenteredAt Tiefenbacher Group, we believe that our expertise must be leveraged for the greater good – to improve patients’ lives worldwide by pioneering healthcare. Our core values of being CURIOSITY DRIVEN, EXCELLENCE FOCUSED, and PATIENT CENTERED guide our actions and decisions every day. These values help us achieve our purpose […]

Tiefenbacher Group Employee Self-Care Day

Tiefenbacher Group - A collage shows Tiefenbacher Group employees in Hyderabad, part of a family-owned pharmaceutical company, enjoying self-care activities like outdoor walks, climbing, cycling, yoga, cooking, and gardening for Employee Self-Care Day.

Employee Self-Care Day at Tiefenbacher Group, Hyderabad, IndiaWe’re thrilled to announce the successful conclusion of our Employee Self-Care Day! Our team in Hyderabad came together for an inspiring self-care talk led by our HODs and fellow employees. The day was filled with valuable insights and shared experiences on personal well-being. Check out some photos of […]

Tiefenbacher Group partnering with Pharmacists Without Borders

Tiefenbacher Group - A blue and yellow flag featuring the Tiefenbacher Group and Apotheker Ohne Grenzen logos waves against the sky. Text below reads: “With Pharmacists Without Borders for better pharmaceutical healthcare solutions in Ukraine.”.

Today we are very pleased to announce that Tiefenbacher Group is expanding the support for Pharmacists Without Borders, a non-profit organization that is close to our hearts and our pharmaceutical business.We have entered into a strategic partnership with Pharmacists Without Borders so that we can support the great work of this association beyond the previous […]

Tiefenbacher Group Pilates & Yoga

Tiefenbacher Group - Large windows overlook a river and cityscape with cranes in the distance. Inside, blue yoga mats are laid out on the floor, sunlight streaming in, with a sign reading "Tiefenbacher Group Morning Pilates/Yoga," reflecting their commitment to pharmaceutical healthcare solutions.

At Tiefenbacher Group, we start the day with Yoga and PilatesAt Tiefenbacher Group, we attach great importance to the well-being and health of our employees. That’s why we offer two free Yoga and Pilates sessions every Tuesday to give our employees the perfect start to the day.  Here are some of the benefits our employees […]

Tiefenbacher Group Social Day 2024

Tiefenbacher Group - A group from the family-owned pharmaceutical company Tiefenbacher Group smile and pose by a canal with pedal boats, enjoying their Social Day 2024 outdoors on a wooden dock.

Tiefenbacher Group Employees Give Back to the CommunityOn the Tiefenbacher Group Social Day 2024, our employees once again took an active role in supporting the local community by volunteering with various charities and organizations in Hamburg. We at the Tiefenbacher Group believe in giving back to the communities in which we live and work, and […]

New laboratory and production site for Oncology medicines

Tiefenbacher Group - A modern building with a blue and white geometric facade, large glass windows, and a loading dock where a truck is parked; ideal for API distribution of finished dosage forms, with a partly cloudy sky above.

Did you know that Tiefenbacher Group is in the final phase of constructing a new, state-of-the-art laboratory and production site for highly potent drugs against cancer and other diseases?The new complex is located at Tiefenbacher Laboratories in Hyderabad, India, and covers a total area of approximately 4,000 m². It provides laboratories with the latest equipment […]

Tiefenbacher Group celebrating US Independence Day

Today is one of the most important public holidays in the United States of America, celebrating its freedom. At the 4th July 1776, by the adoption of the Declaration of Independence, it declared its independence from Great Britain.  On this day, US-Americans all over the world come together to celebrate the spirit of American freedom and […]

Tiefenbacher Group “Bike to work days”

Tiefenbacher Group - People riding bicycles along a sunlit park path near water, with trees providing shade. Overlay text reads "Bike to Work Days 2024." "Tiefenbacher Group," dedicated to pharmaceutical healthcare solutions, is displayed at the top.

This month, some of our valued Tiefenbacher Group colleagues took part in the “Bike to Work Days”. A total of 786 journeys to work were made by bike and an incredible 15,000 kilometers were cycled!Lease a Bike topped up the donation amount to €1 for every kilometer cycled, raising a total of €15,000 for the […]

Tiefenbacher Group Luncheon in Hyderabad

Tiefenbacher Group - A collage features a business luncheon: meeting scenes around a conference table, close-up of Indian food, and a graphic reading "Luncheon & Table Talk with Leadership Team—Conversations on pharmaceutical healthcare solutions in Hyderabad.

It is a tradition at Tiefenbacher Group that our new employees can take part in an open table talk and luncheon with the leadership team, this time in Hyderabad.This involves an open discussion about their first impressions of their new workplace and what they think about the management style, as well as an information session […]

Tiefenbacher Group Football Cup 2024

Tiefenbacher Group - A group of soccer players in white jerseys celebrate with raised arms on a field at sunset. A person in black photographs them. Text reads: "Tiefenbacher Group Cup Winner 2024," honoring a family-owned pharmaceutical company known for healthcare solutions.

Just in time for the start of the UEFA Euro 2024 kick off in Germany, the Tiefenbacher Group in Hamburg organized its annual football tournament.This year, more than 200 people (employees and their families) turned up to join the Tiefenbacher Group Football Cup. They spend a wonderful sunny day playing football together, cheering on the […]

Tiefenbacher Group draws attention to blood donation

Tiefenbacher Group - A collage of four images shows people donating blood, staff preparing medical supplies, a man and woman smiling at a desk, and a graphic with a heart-shaped blood tube, highlighting the message, “Saving lives can be so simple. Donate blood.” API distribution supports this effort.

On today’s World Blood Donor Day, Tiefenbacher Group would like to actively support the Red Cross blood donation services and draw attention to blood donation and its importance for society with the #MissingType campaign.Anyone can suddenly find themselves in need of a blood transfusion. Some accident victims are dependent on 50 or more units of […]

Tiefenbacher New Market Launch: Buprenorphine in Australia

Tiefenbacher Group - An older smiling couple embraces outdoors. The image features the logo "Tiefenbacher Pharmaceuticals," a family-owned pharmaceutical company, and a banner reading "Launch of the analgesic buprenorphine in Australia.

Tiefenbacher Pharmaceuticals successfully prepared the launch of the analgesic Buprenorphine as Transdermal Patch in Australia.We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be affordable and available for all patients around the world. A key point here is that this applies to everyone, regardless of their nationality or income. That´s why we are thrilled […]

Tiefenbacher New Market Launch: Bilastine as Oral Dispersible Tablet (ODT)

Tiefenbacher Group - A young girl with a flower crown sits in a field of wildflowers, holding a tissue to her nose. Text reads: "Launch of the antihistamine bilastine as oral dispersible tablet—a finished dosage form." TIEFENBACHER PHARMACEUTICALS logo appears above.

Tiefenbacher Pharmaceuticals successfully prepared the launch of the antihistamine Bilastine as Oral Dispersible Tablet (ODT) medicine in GermanyAs the allergy season is in full swing, we at Tiefenbacher Group are thrilled to announce that we have successfully prepared the launch of our latest anti-allergy medicine, Bilastine Oral Dispersible Tablet (ODT) in Germany, which is now available […]

Tiefenbacher Group celebrates The International Day of Families

Tiefenbacher Group - A group of thirteen people in business attire stand smiling together outside a historic Gothic-style building, representing leaders in pharmaceutical healthcare solutions and patient-centric drug development.

Today we celebrate The International Day of Families!We would like to use the International Day of Families to talk about our Tiefenbacher Group family. Since 1963 Tiefenbacher Group is a 100% family-owned healthcare company. Until today the company is owned by the direct descendants of our founding father Alfred E. Tiefenbacher. To this day, his unique […]

TIEFENBACHER API + INGREDIENTS offers custom synthesis of intermediates & APIs

Tiefenbacher Group - Illustration of chemistry lab equipment, such as flasks, beakers, microscope, test tubes, and a computer screen showing chemical formulas—highlighting API distribution and finished dosage forms with blue liquid and accents.

Synthesis of Active Pharmaceutical Ingredients (API) : From route scouting to lab scale development to commercial supply Did you know that Tiefenbacher API + Ingredients not only offers a broad range of high-quality APIs, but also offers custom synthesis of intermediates & APIs? The synthesis of APIs is a critical step in the development and […]

Tiefenbacher Group renovation of headquarters in Hamburg

Tiefenbacher Group - Modern office lounge with blue and gray seating, a large plant, and floor-to-ceiling windows overlooking a river and cityscape; Tiefenbacher Group—a family-owned pharmaceutical company focused on patient-centric drug development—logo at the top.

Tiefenbacher Group is keeping you updated on the ongoing renovation of our headquarters at the Port of Hamburg in Germany.This month we reopened our 3rd floor and we are happy to present you some of the results of the remodeling. Our office is becoming a state-of-the-art and innovative workspace that reflects our culture of entrepreneurship, […]

Tiefenbacher Group invites young people to Girls’ & Boys’ Day

Tiefenbacher Group - A group of teenagers and adults pose together indoors in front of large windows. One adult kneels in front, another gives a thumbs up, and the Tiefenbacher Group logo—a family-owned pharmaceutical company focused on patient-centric drug development—is visible above.

Tiefenbacher Group invited some of our employees’ children in Hamburg to spend a day with us at our headquarters to mark Germany’s Future Day for young people. The Girls’ & Boys’ Day or Future Day is a good opportunity not only to familiarize young people with the various career paths. It is also a perfect […]

Tiefenbacher Group celebrates Earth Day 2024

Tiefenbacher Group - Illustration of Earth made from green leaves on a blue background with "EARTH DAY LOVE OUR PLANET" and the Tiefenbacher Group logo, highlighting our commitment to sustainable patient-centric drug development and generic medicines manufacturing.

We are pleased to inform you that TIEFENBACHER GROUP is successfully on its way to becoming climate neutral by the end of 2025*.Every year, Earth Day provides the keynote for a wide range of campaigns on the broad spectrum of environmental and climate protection for everyone to initiate and permanently implement their personal environmental agenda. […]

Tiefenbacher first-to-market launch: Rivaroxaban

Tiefenbacher Group - A smiling older couple embraces outdoors in a garden, looking happy and relaxed. The man wears a blue shirt; the woman, a light pink top. The "Tiefenbacher Pharmaceuticals" logo highlights their family-owned pharmaceutical company in the upper left corner.

Tiefenbacher Pharmaceuticals successfully prepares the launch of the anticoagulant Rivaroxaban.We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be affordable and available for all patients around the world – irrespective of their nationality or income. That´s why we are thrilled to share that we have successfully prepared a day one launch of the generic version of Rivaroxaban.   […]

Tiefenbacher Group welcomes new COO Sandip Tarate

Tiefenbacher Group - A group of men, some holding an orange rope, stand outdoors in front of blooming flowers and a modern building, smiling for a photo as colleagues from a pharmaceutical healthcare solutions team gather behind them.

We are pleased to welcome our new COO for AET Laboratories, Sandip Tarate, to Tiefenbacher Group.Sandip has joined our site in Hyderabad, India, with 23+ years of extensive experience in the pharmaceutical sector. To induct and orient Sandip to Tiefenbacher family, our Managing Director Kristian Ruepp has visited our plant in Hyderabad to ensure a great employee […]

Tiefenbacher Group raises awareness of autism

Tiefenbacher Group - A group of thirteen people in business attire stand smiling together outside a historic Gothic-style building, representing leaders in pharmaceutical healthcare solutions and patient-centric drug development.

Tiefenbacher Group raises awareness of autism on today’s World Autism Awareness Day.The aim of World Autism Awareness Day is to draw attention to the needs and lifelong struggles of autistic people worldwide. It was founded on 2 April 2007 by the United Nations General Assembly. This year is being held across Europe under the motto […]

Tiefenbacher Group awarded EcoVadis silver medal!

Tiefenbacher Group - A smiling girl with glasses raises her arms in excitement next to science equipment, celebrating patient-centric drug development. Beside her is a silver EcoVadis Sustainability Rating medal for March 2024 and the Tiefenbacher API + Ingredients logo on a blue background.

We are excited to share that Tiefenbacher API + Ingredients has been awarded the EcoVadis Silver Medal!EcoVadis is the world’s largest provider of business sustainability ratings. The EcoVadis sustainability assessment methodology is an evaluation of how well a company has integrated the principles of Sustainability/CSR into their business and management system. The Sustainability Scorecard illustrates performance across […]

Tiefenbacher Group celebrates International Women’s Day

Tiefenbacher Group - Illustration of five diverse women standing on a globe, holding signs that say "We can do it," "We are women," and "GRL POWER." The text "International Women's Day" is written on the world, celebrating patient-centric drug development in healthcare.

Today Tiefenbacher Group celebrates International Women’s Day, that’s why we would like to introduce you to two valuable female employees from our company.Get to know the women who are working at Tiefenbacher Group for several years – and take a look at their interesting careers and experiences. They have managed to overcome challenges and successfully […]

Tiefenbacher Group on awareness for rare disease day

Tiefenbacher Group - Logo for Rare Disease Day featuring overlapping colorful handprints in green, blue, and pink, with a central teardrop shape. Highlights patient-centric drug development. “RARE DISEASE DAY®” is written below in bold pink letters.

Tiefenbacher Group draws attention to Rare Disease Day.Today we are focusing on awareness and generating change for the 300 million people worldwide living with rare diseases. Treatment for many rare diseases is insufficient, that´s why we at Tiefenbacher Group are dedicated to protecting and improving lives through innovative healthcare solutions. In the fight against rare diseases, we […]

Tiefenbacher Group supports Pharmacists in Ukraine

Tiefenbacher Group - A man in a traditional embroidered shirt kneels on a riverside deck next to a Ukrainian flag. The Tiefenbacher Group logo, a symbol of patient-centric drug development and pharmaceutical healthcare solutions, is in the upper left corner. Sunlight shines behind him.

Tiefenbacher Group supporting people in Ukraine by donating to Pharmacists without borders.The 24 February 2024, marks the second anniversary of the brutal Russian war against a sovereign Ukraine. Its unbelievable that this war, and with it the suffering of the population in Ukraine, is still ongoing. We all at Tiefenbacher Group are far from forgetting […]

Tiefenbacher Group renovation of headquarters

Tiefenbacher Group - A modern office reception area with a Tiefenbacher Group front desk, large windows overlooking an industrial port, wooden floors, and a glass-walled meeting room—reflecting their focus on patient-centric drug development.

Tiefenbacher Group keeping you updated on the ongoing renovation of our headquarters at the Port of Hamburg in Germany.Tiefenbacher Group is happy to present some of the results of the remodelling and to bring even more changes to life. In accordance with the modern design of the building, we are creating an innovative and state-of-the-art […]

Tiefenbacher Group wishes a Happy Chinese New Year!

Tiefenbacher Group - A vibrant dragon dance is performed in a festive street decorated with red lanterns for Chinese New Year 2024, celebrating the Year of the Dragon. People in colorful costumes, including members of a family-owned pharmaceutical company, watch in the background.

The Chinese New Year is almost here.On the 10th of February, people around the world celebrate the Chinese New Year. They honour this day with carnival events, family gatherings, parades, traditional food, fireworks and other festivities. It is one of the most important public holidays. Incidentally not only in China, but also in many other […]

Tiefenbacher Group together against blood cancer

Tiefenbacher Group - A female healthcare worker smiles and touches foreheads with a young child in a pink headscarf. Text encourages becoming a stem cell donor, highlighting support from pharmaceutical healthcare solutions and providing instructions for eligibility and swab kits.

Tiefenbacher Group and DKMS together against blood cancer!We are pleased to inform you that we have initiated a DKMS registration event during the last week in our headquartes in Hamburg to look for potential donors who are willing to help people with blood cancer or other blood disorders with their blood stem cells. Accordingly to […]

Tiefenbacher speaks out against racism and supports diversity

Tiefenbacher Group - A group of diverse people stand in a circle, stacking their hands to symbolize unity and teamwork. The TIEFENBACHER GROUP logo appears in the top left, reflecting their role as a family-owned pharmaceutical company specializing in finished dosage forms.

Tiefenbacher Group speaks out against racism and supports diversityTiefenbacher recognises its responsibility to be a force for good with its pharmaceuticals. Additionally our wider actions aim to eliminate injustice and create an environment where all people are valued and respected. Diversity and inclusion are fundamental to the way we operate and to our purpose to […]

Tiefenbacher Group AET Laboratories 20th anniversary celebration

Tiefenbacher Group - White "60" with a dotted circle for the zero, next to "Tiefenbacher Group 1963–2023" on a blue background, marking 60 years of excellence in pharmaceutical healthcare solutions and API distribution.

AET Laboratories 20th anniversary celebration was a tremendous success!Last year, we not only celebrated Tiefenbacher Group´s  60th anniversary in Hamburg, but also the 20th anniversary of AET Laboratories – our development and manufacturing site in Hyderabad, India. Before the end-of-year celebrations, some games like cricket, badminton, lemon spoon, tennis kite etc. were conducted for all […]

Tiefenbacher Group wishes you a happy new year!

Tiefenbacher Group - White "60" with a dotted circle for the zero, next to "Tiefenbacher Group 1963–2023" on a blue background, marking 60 years of excellence in pharmaceutical healthcare solutions and API distribution.

As 2024 draws to a close, the Tiefenbacher Group wishes you a Happy New Year and likes to share some of the year’s highlights with you.This year we celebrated many achievements: several international launches of prescription medicines, the preparation for Bilastine’s over-the-counter entry in Germany, the renovation of our Hamburg offices, and the construction of […]

Tiefenbacher New Market Launch: Rivaroxaban in Canada

Tiefenbacher Group - A smiling older woman with short gray hair joyfully gives a piggyback ride to a laughing older man outdoors, highlighting Tiefenbacher Pharmaceuticals' commitment to generic medicines manufacturing. The company logo is in the top left corner.

Tiefenbacher Pharmaceuticals successfully launches the anticoagulant Rivaroxaban on day one in CanadaWe at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be affordable and available for all patients around the world. A key point here is that this applies to everyone, regardless of their nationality or income. That´s why we are thrilled to share that […]

Tiefenbacher Group at CPhI Barcelona 2023

Tiefenbacher Group - A group of people posing for a photo, representing excellence in pharmaceutical healthcare solutions.

Tiefenbacher Group at CPHI Barcelona 2023We are pleased to say that we have had three very successful days full of inspiring meetings at CPHI Barcelona 2023. A big thanks to all who visited us in Barcelona. It was wonderful to meet many familiar and new faces and we are already looking forward to seeing you […]

Tiefenbacher Group 60 years of pioneering healthcare! 

Tiefenbacher Group - White "60" with a dotted circle for the zero, next to "Tiefenbacher Group 1963–2023" on a blue background, marking 60 years of excellence in pharmaceutical healthcare solutions and API distribution.

60 years of pioneering healthcare at Tiefenbacher GroupTiefenbacher Group says “Thank you” to our colleagues from our three main locations in Hamburg (Germany), Hyderabad (India) and Lefkosia (Cyprus) for sharing their short anniversary greetings in their respective national languages with you. At Tiefenbacher Group, we are proud to have a team of 26 different nationalities […]

Tiefenbacher Group 60 years anniversary celebration!

Tiefenbacher Group - White "60" with a dotted circle for the zero, next to "Tiefenbacher Group 1963–2023" on a blue background, marking 60 years of excellence in pharmaceutical healthcare solutions and API distribution.

60 years anniversary celebrationsWe are very happy to announce that Tiefenbacher Group celebrates its 60th anniversary this year! 60 years ago, our founder and pioneer Alfred E. Tiefenbacher started our pharmaceutical business in Germany. 30 years later, we became an European company and today, 60 years later, we are a globally operating company which improves […]

Tiefenbacher Group sustainable impact in Hyderabad/India

Tiefenbacher Group - A person holds a small plant in soil with scientific icons overlayed. On the right, people and a digger are involved in tree planting. Text reads: "Tiefenbacher Group, Environmental responsibility, API distribution, Hyderabad, India.

Tiefenbacher Group relocation of trees in Hyderabad – contribution to our India community to make life better for people and planetAt Tiefenbacher Group, we know that our responsibility as a global healthcare company goes beyond medicine. We understand sustainability as behaving responsibly towards society and our planet. Additionally in our day-to-day work we define sustainability […]

Tiefenbacher New Market Launch: generic launch Teriflunomide

Tiefenbacher Group - A smiling woman in a navy raincoat stands on a beach, holding her hood. The AET TIEFENBACHER PHARMACEUTICALS logo appears in the top left, reflecting their focus on patient-centric drug development. The background shows the sea and greenery.

New market launch: Tiefenbacher Pharmaceuticals successfully launches the generic version of Teriflunomide in more than 20 European countriesTiefenbacher Pharmaceuticals has successfully prepared a day one launch of the generic version of the Multiple Sclerosis (MS) medication Teriflunomide (reference brand name: Aubagio). This complex generic launch explicitly follows Tiefenbacher Group`s strategy to make high quality pharmaceuticals […]

State-of-the-art R&D facilities for powerful drug development

Tiefenbacher Group - A large group gathers outdoors under a colorful canopy for a groundbreaking ceremony as a priest leads rituals. Highlighting Tiefenbacher Group’s family-owned pharmaceutical company and patient-centric drug development, event details frame the image.

State-of-the-art R&D facilities for powerful drug development and manufacturing. New technology for generic, valued added, and innovative pharmaceuticalsWe, at Tiefenbacher Group, go beyond R&D and manufacturing of pharmaceuticals with a commitment to quality, safety, and reliability that is anchored in everything we do. We continuously expand in novel technologies and capabilities to improve quality and […]

Tiefenbacher Group Social Day 2023: Community Engagement

Tiefenbacher Group - A group of about 20 people poses and smiles outdoors under a rainbow decoration, with trees and a building in the background. The blue border features the "Tiefenbacher Group" logo, highlighting their focus on patient-centric drug development.

Tiefenbacher Group Social Day 2023 – contribution through our social and community engagement in HamburgTiefenbacher Group employees get involved in the local community by volunteering with local charities and organizations. Our employees take an active role in giving back to their communities by donating hours to help through a range of volunteer activities.We see ourselves […]

Tiefenbacher Community engagement: School in Hyderabad /India

Tiefenbacher Group - A black play button icon, symbolizing API distribution, is centered on a plain white background.

Tiefenbacher Social Responsibility & Community engagement: New School in Hyderrabad /India – taking action to ensure a positive impact for children and a better future Tiefenbacher supports education for the underprivileged in more than one way. The intent under this objective is to help children break the cycle of poverty, realize their hopes and dreams, […]

TIEFENBACHER API + INGREDIENTS offers Raw Material for Animal Health 

Tiefenbacher Group - Smiling girl with a magnifying glass over one eye stands next to blue text reading "Better Access to a Broad and Innovative Portfolio." Three blue icons below highlight access, quality, and supply from a family-owned pharmaceutical company. TIEFENBACHER API + INGREDIENTS logo is visible.

TIEFENBACHER API + INGREDIENTS offers Raw Material for Animal Health: Companion and Farm AnimalsDid you know that Tiefenbacher API + Ingredients offers in addition to its extensive portfolio of APIs for human health also raw materials in the veterinary field? Animal health affects billions of people around the world. We believe that when animals live […]

OYSTA: Launch of new OYSTA website

Tiefenbacher Group - A black play button icon, symbolizing API distribution, is centered on a plain white background.

Launch of new OYSTA websiteWe are happy that we have launched a new web page for OYSTA – an innovative healthcare brand which we have developed together with our partner OnDosis. With OYSTA, we aim to revolutionize the way how patients take their medicines by combining pharmaceuticals with e-health technology to enable intuitive, precise, and […]

SFDA approves Tiefenbacher facilities

Tiefenbacher Group - Aerial view of Riyadh city skyline at sunset with modern skyscrapers, including the Kingdom Centre, under a dramatic sky. "Tiefenbacher Group" logo is at the top left, representing pharmaceutical healthcare solutions.

Tiefenbacher: Own manufacturing and laboratory facilities successfully registered by the Saudi Food and Drug Authority (SFDA) for GCC regionThe SFDA approves Tiefenbacher facilities! We are happy to announce that our manufacturing and laboratory facilities for oral solids at AET Laboratories in Hyderabad (India) have been successfully registered by the Saudi Food and Drug Authority (SFDA). […]

Tiefenbacher Group is committed to becoming climate neutral

Tiefenbacher Group - Solar panels and wind turbines in a green field with mountains in the background under a blue sky, highlighting TIEFENBACHER GROUP’s commitment to patient-centric drug development. The TIEFENBACHER GROUP logo appears in the top left corner.

Tiefenbacher Group is committed to becoming climate neutral by the end of 2025 – sustainability contribution to make life better for people and planetWe are pleased to share that TIEFENBACHER GROUP is committed to becoming climate neutral by the end of 2025*. As a value-driven healthcare company, dedicated to improving the life of patients worldwide, […]

Tiefenbacher Group: Renovating Headquarters in Hamburg

Tiefenbacher Group - A black play button icon, symbolizing API distribution, is centered on a plain white background.

Tiefenbacher Group: Renovating Headquarters in Hamburg /Germany – an agile, open-plan work spaceTiefenbacher Group is renovating the Headquarters in Hamburg for flexible working while maintaining the importance of the office as a place for collaboration and personal interaction. Did you know that Tiefenbacher Group is currently renovating its headquarters in Hamburg, Germany as a response […]

Tiefenbacher Group at DCAT week 2023

Tiefenbacher Group - A black play button icon, symbolizing API distribution, is centered on a plain white background.

Tiefenbacher Group at DCAT 2023 – Thanks for meeting us in New York City!It has been four very successful and inspiring days for TIEFENBACHER GROUP in New York City. We were delighted to be able to participate in such an important event and look forward to expand these exciting meetings and interesting conversations that we […]

Tiefenbacher Generic Launch: antihistamine Bilastine

Tiefenbacher Group - A smiling young man in a blue shirt lies on his back in green grass with his hands behind his head, reflecting the patient-centric drug development focus of Tiefenbacher Pharmaceuticals. The company’s logo appears in the top left corner.

Generic Launch: Tiefenbacher Pharmaceuticals successfully launches the antihistamine Bilastine for a market entry as over-the-counter (OTC) medicine in germanyGeneric drugs: As the allergy season is starting, we at Tiefenbacher Pharmaceuticals are thrilled to announce that we have successfully prepared the launch of the antihistamine Bilastine for a market entry as Over-the-counter (OTC) medicine in Germany. […]

Tiefenbacher registered by United Arab Emirates Ministry of Health

Tiefenbacher Group - A panoramic cityscape of Dubai with the Burj Khalifa towering over other skyscrapers at sunset, highlighting the Tiefenbacher Group—a family-owned pharmaceutical company known for API distribution—in the upper left corner.

Tiefenbacher Group manufacturing sites have been successfully registered by the United Arab Emirates Ministry of HealthThe Tiefenbacher Group is very excited to announce that our two manufacturing sites at AET Laboratories in Hyderabad (India) and at Delorbis in Lefkosia (Cyprus) have been successfully registered by the United Arab Emirates Ministry of Health! The United Arab […]

Tiefenbacher marks World Cancer Day 2023

Tiefenbacher Group - Four adults stand outdoors holding hands and smiling in a bright, cheerful setting with green trees. The "Tiefenbacher Pharmaceuticals" logo appears in the upper left, highlighting expertise in pharmaceutical healthcare solutions.

TIEFENBACHER marks ‘World Cancer Day 2023’ to increase awareness prevention throughout media togetherTIEFENBACHER joined to harness the power of social media to raise awareness on cancer early detection and prevention. Furthermore we support cancer survivors and build cancer care capacity for people. These efforts are also a contribution to reduce the global burden of cancer. […]

Tiefenbacher Group wishes a happy Chinese New Year 2023!

Tiefenbacher Group - A black play button icon, symbolizing API distribution, is centered on a plain white background.

We at Tiefenbacher Group appreciate the diversity of our colleagues very much and are happy to celebrate their local traditions together. This year, on the 22nd of January, people around the world celebrate the Chinese New Year with carnival events, family gatherings, parades, traditional food, fireworks and other festivities. In the culture of our Chinese […]

Tiefenbacher Group wishes a healthy New Year 2023

Tiefenbacher Group - A black play button icon, symbolizing API distribution, is centered on a plain white background.

From all over the world, we wish you a happy and healthy New Year 2023!Tiefenbacher Group wishes a everyone a healthy New Year. We hope the year 2023 will be as successful and full of unique moments as the past one and we are looking forward to meeting you again in person all over the […]

Tiefenbacher Pharmaceuticals New Market Launch: Apremilast (Psoriasis)

Tiefenbacher Group - A smiling woman in a green top and backpack stands with arms outstretched before lush mountains and fields. The logo and text "Tiefenbacher Pharmaceuticals" highlights their pharmaceutical healthcare solutions in the upper right corner.

New Market Launch: TIEFENBACHER PHARMACEUTICALS successfully launches generic version of the psoriasis medication Apremilast in CanadaWe at Tiefenbacher Pharmaceuticals strive to make our high-quality medicines better affordable and better available for patients around the world. That´s why we are excited to share that we have successfully prepared the launch of the generic version of Apremilast […]

Tiefenbacher Pharmaceuticals New Market Launch: Abiraterone for prostate cancer

Tiefenbacher Group - An older man with gray hair smiles while sitting on a couch, wearing a light gray shirt. The logo and name "AET Tiefenbacher Pharmaceuticals," a family-owned pharmaceutical company, is visible in the upper right corner.

New Market Launch: TIEFENBACHER PHARMACEUTICALS successfully launces generic version of the prostate cancer medicines Abiraterone and the value-added product Abiraterone/PrednisoloneWe at Tiefenbacher Pharmaceuticals aim to improve peoples´ lives around the world by making medicines better affordable, better available, and better than before! That´s why we are excited to share that we have successfully prepared the […]

Thanks for visiting us at CPhI 2022 in Frankfurt!

Tiefenbacher Group - A black play button icon, symbolizing API distribution, is centered on a plain white background.

Tiefenbacher Group: Three Successful Days at CPhI 2023 – Thank you for visiting us in Barcelona! CPHI 2022, the world`s leading pharma event, has just come to an end. It was wonderful to meet our valued customers and partners in person again. Our experts enjoyed three very successful days full of exciting meetings and inspiring discussions. […]

TIEFENBACHER GROUP opens new manufacturing site in Cyprus

Tiefenbacher Group - A black play button icon, symbolizing API distribution, is centered on a plain white background.

TIEFENBACHER GROUP opens new manufacturing site in Cyprus for drug production of high-quality pharmaceuticals – we continuously expand in novel technologies and capabilities to improve quality and boost productivity. Did you know that TIEFENBACHER GROUP heavily invests in its in-house production capacities for high-quality pharmaceuticals? We continuously expand in novel technologies and capabilities to improve […]

TIEFENBACHER GROUP and OnDosis launch the innovative healthcare brand OYSTA®

Tiefenbacher Group - OYSTA logo beside a medical device showing "10 mg" and a smartphone displaying the OYSTA app for mood tracking, dosage management, and health logs—highlighting patient-centric drug development in pharmaceutical healthcare solutions.

TIEFENBACHER GROUP and OnDosis are thrilled to announce the launch of OYSTA®. The new healthcare brand represents the cooperation initiated in September 2020, including the co-development portfolio of innovative products in five indications. OYSTA® aims to revolutionize the way how patients take their medicines by combining pharmaceuticals with e-health technology to enable intuitive, precise, and […]

Tiefenbacher Pharmaceuticals New Market Launch: Apixaban anticoagulant

Tiefenbacher Group - An older man with gray hair, wearing a yellow long-sleeve shirt and backpack, walks in a lush riverside landscape. In the corner, the logo and text read "AET TIEFENBACHER PHARMACEUTICALS," a family-owned pharmaceutical company.

New Market Launch: TIEFENBACHER PHARMACEUTICALS successfully launches generic version of the anticoagulant medicine Apixaban in CanadaWe at Tiefenbacher Pharmaceuticals are driven by enabling people around the world a better access to more affordable high-quality medicines. That´s why we are happy to share that we have successfully prepared the launch of the generic version of Apixaban for […]

Meet TIEFENBACHER GROUP at CPhI 2022 in Frankfurt /Germany

Tiefenbacher Group - Exhibition hall at CPHI 2022 in Frankfurt, featuring the Tiefenbacher Group booth—a family-owned pharmaceutical company specializing in finished dosage forms and API distribution. Bright lighting and displays create a lively atmosphere.

Meet TIEFENBACHER GROUP at CPhI in Frankfurt from 1-3 Nov and discover our latest ideas to make pharmaceuticals more affordable, more available, and better than before!We are very excited to meet our valued customers and partners once again on CPhI 2022, the world´s leading pharma industry event!  Explore our new booth representing Tiefenbacher Group as […]

Meet TIEFENBACHER GROUP at BePharma in Mexico City 2022 from October 10-12!

Tiefenbacher Group - A young child dressed as a doctor smiles and lifts glasses. Text reads: “Looking forward to see you at BePharma | B2B Pharmaceutical Networking, October 10–12, 2022, Mexico City. Pioneering Healthcare. Tiefenbacher Group, a family-owned pharmaceutical company.”.

Meet TIEFENBACHER GROUP at BePharma in Mexico City 2022 from October 10-12!Reach out to AET – Tiefenbacher Group at BePharma the most important Pharma B2B Event in Latin America from October 10-12!  Discover our latest product portfolio in Mexico City and find out how we strive to make pharmaceuticals more affordable, more available, and better than […]

Tiefenbacher Pharmaceuticals New Market Launch: Vildagliptin/Metformin

Tiefenbacher Group - Two older women smiling and hugging outdoors, both appearing joyful. The logo and text “AET TIEFENBACHER PHARMACEUTICALS” is visible in the top left corner, highlighting patient-centric drug development.

NEW Market Launch: TIEFENBACHER PHARMACEUTICALS successfully launches generic version of the diabetes medicine Vildagliptin and Vildagliptin /Metformin in AfricaWe at Tiefenbacher Pharmaceuticals strive to make our high-quality medicines available and affordable to as many people as possible around the world. Therefore Tiefenbacher Group is happy to share that we have successfully prepared the launch of […]

Tiefenbacher: Employee benefits and climate reduction goals

Tiefenbacher Group - A man holding a coffee cup and a woman with a tablet walk together outdoors, smiling at each other, as she walks a bicycle. The TIEFENBACHER GROUP logo in the top right highlights this family-owned pharmaceutical company specializing in finished dosage forms.

Environmentally friendly and health-promoting: TIEFENBACHER GROUP offers bike leasing to employeesEmployees benefits while reducing our impact on the environment with climate reduction goals – we take action on many fronts.As a healthcare company dedicated to improving people’s lives, TIEFENBACHER has a strong belief in the Duty of Care we have for our employees. We take […]

Tiefenbacher Pharmaceuticals New Market Launch: Rivaroxaban

Tiefenbacher Group - A young man and an older man in patterned shirts and a hat smile together outdoors. The AET Tiefenbacher Pharmaceuticals logo appears in the top left corner, highlighting expertise in pharmaceutical healthcare solutions.

Global market launch: TIEFENBACHER PHARMACEUTICALS expands the launch of the anticoagulant medicine Rivaroxaban to Central America and further international marketsWe at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be available for all patients around the world – irrespective of their origin or nationality. That´s why we are happy to share that we have successfully […]

Tiefenbacher Pharmaceuticals New Market Launch: Teriflunomide

Tiefenbacher Group - A smiling woman in a blue rain jacket takes a selfie outdoors by a rocky river, holding her hood with one hand. Trees and misty mountains are in the background. The Tiefenbacher Pharmaceuticals logo highlights patient-centric drug development.

NEW MARKET LAUNCH: TIEFENBACHER PHARMACEUTICALS SUCCESSFULLY LAUNCHES FIRST GENERIC VERSION OF THE MULTIPLE SCLEROSIS MEDICINE TERIFLUNOMIDE IN CANADAWe at Tiefenbacher Pharmaceuticals strive to make our high-quality medicines better affordable and better available for patients around the world. That´s why we are happy to share that we have successfully prepared the launch of the generic version […]

TIEFENBACHER GROUP OPENS NEW SITE FOR HIGHLY POTENT DRUGS IN INDIA

Tiefenbacher Group - A collage showing groups of people smiling, a modern building with the AETI logo, and a hallway lined with scientific equipment highlights pharmaceutical healthcare solutions. The bottom right corner features the TIEFENBACHER GROUP logo.

TIEFENBACHER GROUP opens new site for highly potent drugs in India – we continuously expand in novel technologies and capabilities to improve quality and boost productivity of better healthcareTiefenbacher Group is excited to announce the ceremonious opening of our new highly potent drug laboratory in Hyderabad, India. The completion of the new building is the […]

WORLD HEALTH DAY @ TIEFENBACHER GROUP

Tiefenbacher Group - A diverse group of five older adults stand outdoors in a park, laughing and smiling together. The Tiefenbacher Group logo is displayed in the top left corner, reflecting their commitment to innovative pharmaceutical healthcare solutions.

World Health Day is on the 7th of April each year – this day marks the anniversary of the World Health Organization which was founded in 1948.Today we celebrate World Health Day. This Day marks the anniversay of the World Health Organization (WHO). In times of a global pandemic and a cruel war in Europe, […]

TIEFENBACHER AT DCAT 2022 IN NEW YORK CITY! – Thanks for Meeting us

Tiefenbacher Group - Blue "DCAT" logo in bold, uppercase letters with a registered trademark symbol in the upper right corner and a horizontal blue line beneath the letters, reflecting excellence in generic medicines manufacturing for finished dosage forms.

TIEFENBACHER GROUP AT DCAT 2022 – THANKS FOR MEETING US IN NEW YORK CITY! One of the world´s most important pharma events – DCAT-Week in New York City – has just come to an end. It was four very successful and inspiring days for TIEFENBACHER GROUP presenting our latest product portfolio and innovations to our existing […]

Tiefenbacher Pharmaceuticals New Market Launch: Lacosamide

Tiefenbacher Group - A smiling man gives a piggyback ride to a woman by the sea, both looking happy. The TIEFENBACHER PHARMACEUTICALS logo appears in the top left corner, representing family-owned pharmaceutical company values. The background shows water, grass, and a cloudy sky.

NEW MARKET LAUNCH: TIEFENBACHER PHARMACEUTICALS SUCCESSFULLY LAUNCHES FIRST GENERIC VERSION OF THE EPILEPSY MEDICINE LACOSAMIDE IN AUSTRALIAWe at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be affordable and available for all patients around the world – irrespective of their income level or nationality. That´s why we are happy to share that we have […]

TIEFENBACHER GROUP stands with UKRAINE

Tiefenbacher Group - A modern riverside building at dusk with city lights in the background, overlaid with a transparent blue and yellow filter resembling the Ukrainian flag, symbolizing innovative pharmaceutical healthcare solutions.

Peace and freedom for Ukraine: We, a healthcare company in Europe, stand in solidarity with the people in UkraineTo us at Tiefenbacher Group, it is unbearable to witness what is happening in Ukraine. We condemn the Russian state´s invasion as a brutal act of war against a neighbouring sovereign country. Our thoughts are with everyone […]

MEET TIEFENBACHER GROUP DURING DCAT WEEK IN NEW YORK CITY 2022

Tiefenbacher Group - A young boy dressed as a doctor adjusts his glasses and smiles. Text reads: "Looking forward to see you during DCAT Week, March 20-24th, 2022, New York City. Pioneering patient-centric drug development. Tiefenbacher Group.

Meet TIEFENBACHER GROUP during DCAT week in New York City 2022 from 21-24th march!Reach out to TIEFENBACHER GROUP at DCAT in New York City from 21-24th March and discover our latest ideas to make pharmaceuticals more affordable, more available, and better than before! Contact us to schedule a meeting via info@aet.eu. For information about our […]

TIEFENBACHER GROUP WISHES A HAPPY AND HEALTHY NEW YEAR 2022 FROM ALL OVER THE WORLD!

Tiefenbacher Group - A new school building in India features animal murals, a decorated pillar, and a Telugu sign above the entrance. A blue banner reads "New School Building in India." The TIEFENBACHER GROUP logo, representing a family-owned pharmaceutical company, is in the corner.

We at TIEFENBACHER GROUP wish you a happy and healthy new year 2022 from all over the world! Please watch the short video for our new year greetings from our colleagues from our three main locations in Hamburg (Germany), Hyderabad (India) and Lefkosia (Cyprus). For information about our product portfolio and innovative health care solutions […]

TIEFENBACHER GROUP enlarges its manufacturing facilities in India and Cyprus

Tiefenbacher Group - A collage showcases Tiefenbacher Group facilities, highlighting modern glass-fronted offices, industrial buildings, manufacturing equipment, and the Tiefenbacher Group logo, reflecting their commitment to patient-centric drug development and pharmaceutical healthcare solutions.

Driving efficiency is our key – TIEFENBACHER GROUP enlarges its manufacturing facilities in India and Cyprus for powerful drug productionDid you know that TIEFENBACHER GROUP heavily invests in its own manufacturing facilities to secure an efficient and reliable supply of our high-quality pharmaceuticals for patients around the world? As fully integrated pharmaceutical company, we offer […]

TIEFENBACHER GROUP at CPhI 2021 in Milano – thank you for visiting us!

Tiefenbacher Group - A black play button icon, symbolizing API distribution, is centered on a plain white background.

Tiefenbacher Group: Three Successful Days at CPHI 2021 in Milano – Thank you for visiting usWith over 1,300 exhibitors and more than 20,000 attendees the world`s leading pharma eventt CPHI has just come to an end. It was three very successful days for TIEFENBACHER GROUP presenting our latest product portfolio and innovations at Fiera Milano. […]

TIEFENBACHER GROUP: New school building in India

Tiefenbacher Group - A new school building in India features animal murals, a decorated pillar, and a Telugu sign above the entrance. A blue banner reads "New School Building in India." The TIEFENBACHER GROUP logo, representing a family-owned pharmaceutical company, is in the corner.

At TIEFENBACHER GROUP giving back to society is important to us: New school building in India As a value-driven healthcare company, dedicated to improve the life of patients worldwide, we believe that it´s our responsibility to care about the environment and society – especially in the countries in which we operate. That’s why we are […]

TIEFENBACHER GROUP at CPhI in Milan 2021

Tiefenbacher Group - A modern exhibition booth for TIEFENBACHER GROUP, a family-owned pharmaceutical company, features a bold blue design, illuminated logo, reception counter, and several people interacting inside a convention or trade show setting.

Reach out to the TIEFENBACHER GROUP at CPHI in Milan 2021 and discover our latest innovations to make pharmaceuticals more affordable, more available, and better than before.“Nothing can replace meeting each other in person!” says Oliver Schrader, Managing Director of Tiefenbacher Group. After nearly two years of mainly digital work, we are very excited to […]

Tiefenbacher Pharmaceuticals: Launch of first generic version of the antihistamine Bilastine

Tiefenbacher Group - A smiling woman with long hair stands in a field of yellow flowers under a clear sky. The Tiefenbacher Pharmaceuticals logo in the top left highlights their dedication to patient-centric drug development and innovative pharmaceutical healthcare solutions.

New market launch: TIEFENBACHER PHARMACEUTICALS successfully launches first generic version of the antihistamine BilastineWe at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be affordable for all patients irrespective of their income level or nationality. That´s why we are excited to share that we have successfully launched the first generic version of Bilastine (20 […]

New agreement expands collaboration between OnDosis and TIEFENBACHER GROUP

Tiefenbacher Group - Two white and teal handheld medical devices with digital displays showing “10 mg,” next to the Tiefenbacher Group and Ondosis logos, highlight advanced pharmaceutical healthcare solutions for finished dosage forms on a white background.

Innovative Healthcare Pharmaceuticals with e-health technology in the ADHD field, rare diseases, and transplantation medicineSwedish Life science company OnDosis and German B2B pharmaceutical company TIEFENBACHER GROUP initiate four new innovative development projects targeting ADHD, rare diseases, and transplantation medicine. The idea is to improve the health and everyday lives of millions of patients by giving […]

TIEFENBACHER GROUP supports Post COVID-19 with Posaconazole against Black Fungus (Mucormycosis)

Tiefenbacher Group - A scientist wearing safety goggles and a lab coat closely observes equipment in a laboratory focused on patient-centric drug development, surrounded by scientific instruments and glassware.

TIEFENBACHER GROUP supports Post COVID-19 with Posaconazole tablets against Black Fungus (Mucormycosis) in IndiaBlack Fungus (Mucormycosis) is dramatically spreading in India connected to the extensive 2nd COVID-19 wave. The highly life-threatening disease usually occurs as a rare disease in immunocompromised patients. However, many patients who have survived their COVID-19 infection with the help of external […]

TIEFENBACHER GROUP announces global launch of TIEFENBACHER MEDICAL DEVICES

Tiefenbacher Group - A young girl wearing glasses and a white lab coat smiles and points upward, standing next to the text "Tiefenbacher Medical Devices," representing innovative pharmaceutical healthcare solutions on a light background.

Innovation healthcare by combining established drug-based medicines with medical devices and digital healthAfter more than five years in operation, TIEFENBACHER GROUP transfer its medical device business into a new stand-alone company: TIEFENBACHER MEDICAL DEVICES. The launch follows TIEFENBACHER GROUP´s strategy to offer better patient therapies by combining established drug-based medicines with medical devices and digital […]

TIEFENBACHER API + INGREDIENTS: FIRST API BASED ON GREEN CHEMISTRY

Tiefenbacher Group - Hands holding soil with a small green seedling, surrounded by digital chemical formulas and hexagons, with sunlight shining in a blurred green background, symbolizing science and growth in pharmaceutical healthcare solutions.

TIEFENBACHER API + INGREDIENTS starts to offer the first API based on green chemistryWe at TIEFENBACHER API + INGREDIENTS are committed to drive greem chemistry in the pharmaceutical raw material industry. Enviero Progesterone is an Active Pharmaceutical Ingredient (API) and the first molecule from TIEFENBACHER API + INGREDIENTS’ green-chemistry program by providing the latest in lower environmental […]

TIEFENBACHER PHARMACEUTICALS: Launch of generic version of Teriflunomide, Multiple Sclerosis (MS)

Tiefenbacher Group - A group of five older adults, three men and two women, stand close together outdoors, smiling and laughing under leafy trees on a sunny day, reflecting the joy that patient-centric drug development brings to thriving communities in a lush park setting.

TIEFENBACHER PHARMACEUTICALS announces global generic launch of Teriflunomide – making multiple sclerosis therapy more affordable and better available worldwideTiefenbacher Pharmaceuticals has successfully developed a global dossier for a generic version of Teriflunomide 7 mg and 14 mgfilm-coated tablets. Generics are therapeutically equivalent to their branded counterparts with a lower price due to losing patent protection. Teriflunomide […]

AET Pharma US Inc., Part of Tiefenbacher, approval of Abbreviated New Drug Application (ANDA) for Posaconazole

Tiefenbacher Group - A large group of people, including men and women in formal and colorful traditional attire, stand on a grassy lawn with a modern glass building behind them, reflecting the unity of a family-owned pharmaceutical company dedicated to patient-centric drug development.

AET Pharma US Inc. announces successful approval of Abbreviated New Drug Application (ANDA) for PosaconazoleOn 1st February 2021, AET Pharma US Inc, part of TIEFENBACHER GROUP, received FDA approval of the Abbreviated New Drug Application (ANDA) for Posaconazole in 100 mg Delayed-Release Tablets. This is another milestone for TIEFENBACHER GROUP in further strengthening its product […]

TIEFENBACHER PHARMACEUTICALS: Launch of Rivaroxaban

Tiefenbacher Group - Blister packs of white pills and capsules are arranged on a white surface, overlaid with translucent blue hexagons and digital interface elements, reflecting patient-centric drug development by a family-owned pharmaceutical company.

TIEFENBACHER PHARMACEUTICALS announces global launch of Rivaroxaban – an anticoagulant medication (blood thinner)Tiefenbacher Pharmaceuticals, part of Tiefenbacher Group, is pleased to announce the availability of a registration dossier for the generic of Rivaroxaban 2.5 mg, 10 mg, 15 mg and 20 mg film-coated tablets. Generics are therapeutically equivalent to their branded counterparts with a lower […]

International Brand Relaunch of Tiefenbacher Group

Tiefenbacher Group - A man in a dark suit and glasses sits on a chair by a large window overlooking modern office buildings and a waterfront. He is smiling, has short, light hair, and projects the professionalism of a family-owned pharmaceutical company.

Tiefenbacher Group: Improving people’s life by making pharmaceuticals more affordable, more available, and better than before”We are very excited to launch the new Tiefenbacher Group website. It represents the fundamental changes which we have started in the recent years. We are on the move to drive important efficiencies in our supply chain and become a […]

Tiefenbacher Group and OnDosis enter a partnership for medicines and digital health

Tiefenbacher Group - Logos of Tiefenbacher Group (blue dots and text) and Ondosis (green and maroon text with a capsule icon) on a white background, representing leaders in patient-centric drug development and pharmaceutical healthcare solutions.

Tiefenbacher Group and OnDosis today announced the signing of an extensive co-development agreement for multiple products in the upcoming years. This collaboration strengthens both companies’ commitment to further develop and commercialize innovative products within individualized treatments and digital health, combining traditional drug-based medicines with digital therapeutics and intelligent dosing. TIEFENBACHER GROUP and OnDosis enter a […]

TIEFENBACHER GROUP SUMMER EVENT 2023

Tiefenbacher Group - A group of about 20 people poses and smiles outdoors under a rainbow decoration, with trees and a building in the background. The blue border features the "Tiefenbacher Group" logo, highlighting their focus on patient-centric drug development.

For our Tiefenbacher Group Social Day we have given our employees in #hamburg time off so that they can get socially involved in an institution in the Hanseatic city. We want to promote the common good in our beloved city and therefore supported the Tierpark Hagenbeck (zoo), the Sternbrücke Children’s Hospice, the Stiftung Das Rauhe Haus (child and youth welfare), the alsterdorf […]

Get in touch